Advanced searches left 3/3

Acquired Immune - Europe PMC

Summarized by Plex Scholar
Last Updated: 04 February 2022

* If you want to update the article please login/register

Vaccination in pediatric acquired inflammatory immune-mediated neuromuscular disorders.

Aim To examine literature on vaccination-related induction, epidemiologic expansion of the disease and disease reccurrences, as well as vaccine safety and effectiveness among pediatric patients with acquired inflammatory immune-mediated neuromuscular disorders. Impunization against influenza, quadrivalent conjugated meningococcal vaccine, and pneumococcal disease has been recommended in Caution, as well as avoiding tetanus toxoid immunization in CIDP patients. Before starting immunosupressive therapy, patients with immune-mediated acquired NMD should be vaccinated with live vaccines. Patients with low protective antibody titers should be considered for reaccination.

Source link: https://europepmc.org/article/MED/34998097


Retrovirus-derived acquired genes, RTL5 and RTL6, are novel constituents of the innate immune system in the eutherian brain

RTL5 and RTL6 are microglial genes that play a role in the front line of brain innate immune responses to specific pathogens, according to here. In microglia and RTL6-Venus fusion proteins were expressed in microglia and as extracellular granules in the central nervus system, and displayed rapid responses to pathogens including lipopolysaccharide, double-stranded RNA analog, and non-methylated CpG DNA in the Venus and mCherry knock-in mice, as well as extracellular granules, showing a rapid reaction to pathogens Retrovirus-derived genes are thought to play a role in the innate immune system of the eutherian brain, according to this study.

Source link: https://europepmc.org/article/PPR/PPR437985


Hypoplastic myelodysplastic syndrome and acquired aplastic anemia: Immune‑mediated bone marrow failure syndromes (Review).

Hypoplastic myelodysplastic syndrome and aplastic anemia are two uncommon hematopoietic disorders characterized by pancytopenia with hypoplastic bone marrow. Patients with hMDS are at a higher risk of neoplastic disease, a shorter life time, and a lower response to immunosuppressive therapy than patients with AA. Cellular damage by cytotoxic T cells reveals convincing evidence that these two distinct medical entities share a common pathophysiology based on the destruction of hematopoietic stem and progenitor cells. Expanded T cells overproduce proinflammatory cytokines, resulting in reduced proliferation and increased apoptosis of HSPCs. The antigens that cause this abnormal immune reaction are not known, but potential candidates have been suggested, including Wilms tumor protein 1 and human leukocyte antigen class I molecules, including Wilms tumor protein 1 and human leukocyte antigen class I molecules. The present study explores the main clinicopathological differences between hMDS and acquired AA, focusing on the molecular background and emphasizing molecular testing.

Source link: https://europepmc.org/article/MED/34958107


Nature of Acquired Immune Responses, Epitope Specificity and Resultant Protection from SARS-CoV-2.

The key global reaction to the SARS-CoV-2 pandemic has been to bring as quickly as possible a variety of vaccines that are supposed to raise immunity to this viral disease. In contrast, however, there had already significant past research that showed that respiratory infections in mucosal surfaces were resistant to immune clearance by mechanisms not characteristic of systemic pathogens, as pointed out in the essay. According to the study, it was likely to be crucial to both innate and acquired immunity in response to viral infections, as well as the right acquired immune resistance mechanisms for viral clearance. As host immunity develops, a completely predictable reaction to the subsequent evolution of viral variants that has sparked such widespread concern over the last 3-6 months as host immunity develops was a predictable reaction.

Source link: https://europepmc.org/article/MED/34945725


Immune Profiling Demonstrates a Common Immune Signature of Delayed Acquired Immunodeficiency in Patients With Various Etiologies of Severe Injury.

Measurements and key findings Extensive immune profiling was carried out on days 1-2, 3-4, and 5-7 after inclusion using a panel of 30 common immune markers. In contrast, persistence in a subgroup of patients of severe immune impairments at the end of the first week after admission was linked to an elevated risk of secondary infections independent of exposure to surgical devices. Conclusions Using a low immunological marker, we discovered delayed injury-acquired immunodeficiency in a subset of critically wounded patients without having primary disease. To find specific hypothesis allowing for the identification of biological pathways influencing altered immune function in the setting of acute systemic disease, such immune monitoring must be expanded into larger study cohorts with more extensive immune surveillance to produce a specific hypothesis that allows for the identification of biological pathways that influence altered immune function in the context of acute systemic injuries.

Source link: https://europepmc.org/article/MED/34534131

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions